Pricing Log in Create free account

Actinium Pharmaceuticals, Inc. (ATNM) vs LianBio Sponsored ADR (LIANY)

Actinium Pharmaceuticals, Inc. and LianBio Sponsored ADR are both Biotechnology companies. Actinium Pharmaceuticals, Inc. and LianBio Sponsored ADR are of similar size ($34.2M and $33.3M). LianBio Sponsored ADR trades at the lower P/E: 0.0× against 3.1×. Actinium Pharmaceuticals, Inc. has the higher net margin (32.2% vs 0.00%) and the higher return on invested capital (0.00% vs −450.5%). Across the 14 metrics below, LianBio Sponsored ADR leads on 9 and Actinium Pharmaceuticals, Inc. on 5.

Valuation

Metric ATNM LIANY Biotechnology median
P/E 3.14 0.02 8.50
P/S 1.01 n/m 9.71
P/B 1.17 0.01 2.13
Price to free cash flow n/m 0.02 20.82
EV/EBITDA n/m 5.72 0.64
EV/Sales (0.03) n/m 9.21
Earnings yield 31.86% 5,773.40% (33.15%)
Free cash flow yield (65.52%) 4,795.89% (25.50%)

Profitability

Metric ATNM LIANY Biotechnology median
Gross margin 98.71% 0.00% 65.16%
Operating margin 27.20% 0.00% 0.00%
Net margin 32.18% 0.00% 0.00%
Free cash flow margin (66.16%) 0.00% 0.00%
Return on equity 45.86% 70.96% (56.36%)
Return on assets 21.92% 66.19% (48.04%)
Return on invested capital 0.00% (450.47%) 0.00%

Growth

Metric ATNM LIANY Biotechnology median
Revenue growth (TTM) 2,731.18% — 6.02%
EPS growth (last fiscal year) 14.17% 75.44% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATNM LIANY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.08 17.03 4.72
Net debt to EBITDA 1.35 7.41 0.96

Dividend

Metric ATNM LIANY Biotechnology median
Dividend yield — 0.00% 0.09%
Payout ratio — — —

Size

Metric ATNM LIANY Biotechnology median
Market cap 33.32m 34.19m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack